Angiodroid Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Angiodroid General Information

Description

Developer of medical devices designed to perform automated carbon dioxide angiography. The company's patented injection system provides a biocompatible alternative to iodine contrast media, enabling healthcare providers to conduct safer diagnostic and interventional procedures that preserve renal function and eliminate allergic reactions while maintaining high-quality radiological imaging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Speranza 35
  • San Lazzaro di Savena
  • 40068 Bologna
  • Italy
+39 051
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Via Speranza 35
  • San Lazzaro di Savena
  • 40068 Bologna
  • Italy
+39 051

Angiodroid Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angiodroid Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Mar-2026 Completed Generating Revenue
5. Later Stage VC (Series A) 27-Feb-2023 Completed Generating Revenue
4. Accelerator/Incubator 24-May-2021 Completed Generating Revenue
3. Equity Crowdfunding 13-Oct-2020 Cancelled Generating Revenue
2. Early Stage VC (Series A) 17-Jul-2015 $1.67M $2.89M Completed Generating Revenue
1. Seed Round 22-Oct-2013 $1.22M $1.22M Completed Generating Revenue
To view Angiodroid’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Angiodroid Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to perform automated carbon dioxide angiography. The company's patented injection
Diagnostic Equipment
Bologna, Italy
28 As of 2026

Billerica, MA
 

Cincinnati, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Angiodroid Competitors (8)

One of Angiodroid’s 8 competitors is Access Vascular, a Venture Capital-Backed company based in Billerica, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Access Vascular Venture Capital-Backed Billerica, MA
Mammotome Formerly PE-Backed Cincinnati, OH
Oxylitre (a division of Oxylitre Holdings Limited) Corporation Manchester, United Kingdom
Lightpoint Medical Formerly VC-backed Amersham, United Kingdom
SOMATEX Medical Technologies Formerly PE-Backed Berlin, Germany
You’re viewing 5 of 8 competitors. Get the full list »

Angiodroid Patents

Angiodroid Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3966781-A1 Method for the improvement of radiological images in the course of an angiography Active 07-May-2019
EP-3966781-B1 Method for the improvement of radiological images in the course of an angiography Active 07-May-2019
EP-3966781-C0 Method for the improvement of radiological images in the course of an angiography Active 07-May-2019
US-12136147-B2 Method for the improvement of radiological images in the course of an angiography Active 07-May-2019
US-20220230368-A1 Method for the improvement of radiological images in the course of an angiography Active 07-May-2019 G06T12/30
To view Angiodroid’s complete patent history, request access »

Angiodroid Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angiodroid Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
8a + Investimenti Asset Manager Minority
Air Liquide Venture Capital Corporate Venture Capital Minority
CDP Venture Capital (Rome) Venture Capital Minority
UniCredit Start Lab Accelerator/Incubator
Sparkbio Corporation Minority
To view Angiodroid’s complete investors history, request access »

Angiodroid FAQs

  • When was Angiodroid founded?

    Angiodroid was founded in 2013.

  • Where is Angiodroid headquartered?

    Angiodroid is headquartered in Bologna, Italy.

  • What is the size of Angiodroid?

    Angiodroid has 28 total employees.

  • What industry is Angiodroid in?

    Angiodroid’s primary industry is Diagnostic Equipment.

  • Is Angiodroid a private or public company?

    Angiodroid is a Private company.

  • What is Angiodroid’s current revenue?

    The current revenue for Angiodroid is .

  • How much funding has Angiodroid raised over time?

    Angiodroid has raised $8.26M.

  • Who are Angiodroid’s investors?

    8a + Investimenti, Air Liquide Venture Capital, CDP Venture Capital (Rome), UniCredit Start Lab, and Sparkbio have invested in Angiodroid.

  • Who are Angiodroid’s competitors?

    Access Vascular, Mammotome, Oxylitre (a division of Oxylitre Holdings Limited), Lightpoint Medical, and SOMATEX Medical Technologies are some of the 8 competitors of Angiodroid.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process